Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Network of nuclear receptor ligands in multiple sclerosis: Common pathways and interactions of sex-steroids, corticosteroids and vitamin D3-derived molecules.
Th1, Th2 and Th17 Cytokine Profile in Patients with Multiple Sclerosis Following Treatment with Rapamycin.
A new dawn for genetic association studies in multiple sclerosis.
Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NFκB.
Pharmaceutical Approval Update.
Recent updates on molecular genetic engineering approaches and applications of human therapeutic proteins.
Brain atrophy after bone marrow transplantation for treatment of multiple sclerosis.
Rituximab for treating multiple sclerosis: Off-label but on target.
[Fingolimod: effectiveness and safety in routine clinical practice. An observational, retrospective, multi-centre study in Galicia].
Multiple sclerosis and alcohol use disorders: In-hospital mortality, extended hospital stays, and overexpenditures.
Efficacy and safety of cutting balloons for the treatment of obstructive lesions in the internal jugular veins.
Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial.
TLR4 Deficiency Impairs Oligodendrocyte Formation in the Injured Spinal Cord.
The Incidence of Euphoria in Multiple Sclerosis: Artefact of Measure.
Ultrasound pattern sum score, homogeneity score and regional nerve enlargement index for differentiation of demyelinating inflammatory and hereditary neuropathies.
Guillain-Barré Syndrome Associated with Zika Virus Infection in Colombia.
Long-term effects of autoimmune CNS inflammation on adult hippocampal neurogenesis.
A novel highly selective 5-HT6 receptor antagonist attenuates ethanol and nicotine seeking but does not affect inhibitory response control in Wistar rats.
Acute Disseminated Encephalomyelitis.
Hemoglobins as new players in multiple sclerosis: metabolic and immune aspects.
No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.
Gut microflora and multiple sclerosis.
Rasch analysis of the Fatigue Severity Scale in Italian subjects with multiple sclerosis.
Treatment with NAD(+) inhibited experimental autoimmune encephalomyelitis by activating AMPK/SIRT1 signaling pathway and modulating Th1/Th17 immune responses in mice.
Incidence, characterization, and clinical impact analysis of peginterferon beta1a immunogenicity in patients with multiple sclerosis in the ADVANCE trial.

Pages